Curis | CRIS - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 9.19B 532M 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Bristol-Myers Squibb USD 20.07B 1.6B 2026-03
CSL USD 18.66B 2.75B 2025-12
Curis USD 5.46M 19.45M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Exelixis USD 1.94B 225.57M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Incyte USD 5.62B 455.37M 2026-03
Merck USD 45.88B 6.73B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Pfizer USD 90.1B 3.63B 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Takeda JPY 7.77T 129.5B 2026-03
TG Therapeutics USD 583.13M 64.89M 2026-03
Verastem USD 57.2M 72.72M 2025-12
Xoma USD 87.94M 15.5M 2025-09